UPDATE 3-New Novartis CEO feels heat on U.S. generics business
April 19, 2018 at 05:37 AM EDT
* Cosentyx sales miss average analyst forecast (Recasts story to focus on Cosentyx, Sandoz; adds share performance)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|